Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 67.08 |
| Open | 67.45 |
| Bid | 65.26 x 400 |
| Ask | 65.33 x 200 |
| Day's Range | 65.09 - 67.90 |
| 52 Week Range | 65.09 - 87.87 |
| Volume | |
| Avg. Volume | 7,349,480 |
| Market Cap | 81.39B |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 14.50 |
| EPS (TTM) | 4.50 |
| Earnings Date | Apr 25, 2024 |
| Forward Dividend & Yield | 3.08 (4.72%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | 78.36 |
- GuruFocus.com
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Explore Gilead's latest financial performance and strategic directions, including updates on HIV, oncology, and liver disease segments.
ZacksGilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Barrons.comGilead Beats Earnings Expectations After Rocky Quarter
The biotech reported a loss for the quarter of $1.32 per share, better than the FactSet consensus estimate of a loss of $1.49 per share.
© 2024 Yahoo. All rights reserved.